Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             25 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity Khanam, Saima
2009
27 43 p. 6011-6021
11 p.
artikel
2 A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine Ambrozaitis, Arvydas
2009
27 43 p. 6022-6029
8 p.
artikel
3 Antibody kinetics among 8–10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later Gilca, Vladimir
2009
27 43 p. 6048-6053
6 p.
artikel
4 A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy Gandhi, Rajesh T.
2009
27 43 p. 6088-6094
7 p.
artikel
5 Cloning and characterization of Rhipicephalus appendiculatus voraxinα and its effect as anti-tick vaccine Yamada, Shinji
2009
27 43 p. 5989-5997
9 p.
artikel
6 Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy Dirix, V.
2009
27 43 p. 6042-6047
6 p.
artikel
7 Decision support in vaccination policies Piso, B.
2009
27 43 p. 5923-5928
6 p.
artikel
8 Development of an ex vivo human skin model for intradermal vaccination: Tissue viability and Langerhans cell behaviour Ng, Keng Wooi
2009
27 43 p. 5948-5955
8 p.
artikel
9 Editorial Board 2009
27 43 p. CO2-
1 p.
artikel
10 Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion Baldwin, Susan L.
2009
27 43 p. 5956-5963
8 p.
artikel
11 Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus Li, Yaoming
2009
27 43 p. 6004-6010
7 p.
artikel
12 First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin Bouchez, V.
2009
27 43 p. 6034-6041
8 p.
artikel
13 Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies? Leonardi, S.
2009
27 43 p. 6030-6033
4 p.
artikel
14 Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine Wu, Fan
2009
27 43 p. 6095-6101
7 p.
artikel
15 HPV 18 antibody levels, clinical efficacy and induced immune memory: A trio? Tjalma, Wiebren A.A.
2009
27 43 p. 5921-5922
2 p.
artikel
16 Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity Khan, Sheema
2009
27 43 p. 6080-6087
8 p.
artikel
17 Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity Yuki, Yoshikazu
2009
27 43 p. 5982-5988
7 p.
artikel
18 Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses Alberini, Isabella
2009
27 43 p. 5998-6003
6 p.
artikel
19 Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents—Benefit of universal infant hepatitis B vaccination Shuler, Carrie M.
2009
27 43 p. 5942-5947
6 p.
artikel
20 Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study Phua, K.B.
2009
27 43 p. 5936-5941
6 p.
artikel
21 Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysis Ginsberg, Gary Michael
2009
27 43 p. 6060-6079
20 p.
artikel
22 The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection Carcelén, J.
2009
27 43 p. 5964-5973
10 p.
artikel
23 Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins Liu, Jun
2009
27 43 p. 5929-5935
7 p.
artikel
24 Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines Zhu, Daming
2009
27 43 p. 6054-6059
6 p.
artikel
25 Viscerotropic disease following yellow fever vaccination in Peru Whittembury, Alvaro
2009
27 43 p. 5974-5981
8 p.
artikel
                             25 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland